Calynn Formulations Private Limited

Calynn Formulations Private Limited - healthcare in Hyderabad, Telangana, India. Directors, charges & compliance details.
CIN U33113TG2020PTC143217 Incorporated 26 August 2020 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company healthcare MSME · Micro
Data last updated
Revenue · FY 2025
₹8.34 Lakh
▲ 74% YoY
Net profit · FY 2025
₹2.61 Lakh
Net margin 31.3%
EBITDA · FY 2025
₹2.61 Lakh
EBITDA margin 31.3%
Authorised capital
₹17 Lakh
Registered with MCA
Paid-up capital
₹17 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date

About Calynn Formulations Private Limited

Data last updated:

Calynn Formulations Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the medical and surgical equipment segment of the healthcare sector. It was incorporated on 26 August 2020 and has been in existence for over 6 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U33113TG2020PTC143217.

The company has an authorised share capital of ₹17 Lakh and a paid-up capital of ₹17 Lakh. It is led by directors Mariappan Anuradha and Amarnath Reddy Parvatha Reddy.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H No 5 35/Ns – B/503 Saibaba Colony Kukatpally, Hyderabad, Telangana, India – 500072.

As per the financials filed for FY 2025, the company reported a revenue of ₹8.34 Lakh, a growth of 74% compared to the previous year. For the same year it recorded a net profit of ₹2.61 Lakh (net margin 31.3%) and EBITDA of ₹2.61 Lakh (EBITDA margin 31.3%). Revenue has grown at a compounded annual rate (CAGR) of 118% over three years.

Calynn Formulations Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0004826).

Company details

CIN U33113TG2020PTC143217
Registration Number 143217
Incorporation Date 26 August 2020
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-TS-02-0004826

Recognitions & Rankings of Calynn Formulations

MSME (Udyam registered) Ministry of MSME
Category
Micro (2022-23)
Udyam number
UDYAM-TS-02-0004826

Contact details

Calynn Formulations Private Limited's registered office is in Hyderabad, Telangana.

  • Registered Address
    H No 5 35/Ns – B/503 Saibaba Colony Kukatpally, Hyderabad, Telangana, India – 500072
  • Industry
    Healthcare, Medical & Surgical Equipment, Manufacturing, Sterilizers, Orthopedic Appliances, Medical Appliances And Instruments
Comprehensive company report
Calynn Formulations Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Calynn Formulations Private Limited

FY 2025 filings available

Calynn Formulations Private Limited reported revenue of ₹8.34 Lakh (up 74% YoY) for FY 2025.

Revenue · FY 2025
₹8.34 Lakh ▲ 74%
Net profit · FY 2025
₹2.61 Lakh margin 31.3%
EBITDA · FY 2025
₹2.61 Lakh margin 31.3%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 74%
3 years · compounded
▲ 118%
EBITDA CAGR growth
1 year
▲ 190%
3 years · compounded
▲ 46%

Revenue has grown at a compounded annual rate (CAGR) of 118% over three years, including 74% growth in the latest year. EBITDA rose 190% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹2.61 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹2.61 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin31.3%
Net Profit Margin31.3%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Calynn Formulations Private Limited, buy the company report.

Board of directors of Calynn Formulations Private Limited

Calynn Formulations has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Mariappan AnuradhaDirector07 Aug 20233 Years 2 MonthsCurrent
Amarnath Reddy Parvatha ReddyDirector26 Aug 20206 Years 2 MonthsCurrent

Peer comparison

Calynn Formulations Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Oreck Pharma Private Limited₹8.46 Lakh (FY 2022)283.0%Thane, Maharashtra, India
Sri Vishnu Organics Private Limited₹8.43 Lakh (FY 2016)-75.0%Thiruvallur, Tamil Nadu, India
Glorious Bio Care Private Limited₹8.43 Lakh (FY 2024)20.0%Wadhwan, Gujarat, India
Kaytross Healthcare Limited₹8.41 Lakh (FY 2023)-8.0%Mumbai, Maharashtra, India
Sirus Pharma Marketing Pvt Ltd₹8.38 Lakh (FY 2024)3.0%Meghalaya, India
Calynn Formulations Private Limitedthis company₹8.34 Lakh (FY 2025)₹2.61 Lakh31.3%74.0%Hyderabad, Telangana, India
Richmond Biosciences Private Limited₹8.29 Lakh (FY 2022)-69.0%Secunderabad, Telangana, India
Letos Lifesciences Private Limited₹8.28 Lakh (FY 2024)Ahmedabad, Gujarat, India
Hamara Remedies Private Limited₹8.24 Lakh (FY 2024)-39.0%Saharanpur, Uttar Pradesh, India
Cam Neuro Pharma Private Limited₹8.21 Lakh (FY 2024)-84.0%Cuttack Sadar, Odisha, India
Lusek Medicare Private Limited₹8.21 Lakh (FY 2025)932.0%Mumbai, Maharashtra, India

To see the full peer comparison of Calynn Formulations Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Calynn Formulations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Calynn Formulations Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Calynn Formulations Private Limited has 4 board changes on record since 2020: 2 appointments and 2 cessations. The latest: Mariappan Anuradha ceased to be Additional Director on 29 Sep 2023.

AGM
Calynn Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Calynn Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Ceased
Mariappan Anuradha ceased to be Additional Director.
Ceased
Janardhana Reddy Pravatareddy ceased to be Director.
Appointed
Mariappan Anuradha was appointed as Director.
Appointed
Amarnath Reddy Parvatha Reddy was appointed as Director.
Incorporation
26 Aug 2020
Calynn Formulations Private Limited was registered on 26 Aug 2020 with Roc Hyderabad & aged 6 years 2 months as per MCA records.

Frequently asked questions

Calynn Formulations is an active private limited company based in Hyderabad, Telangana, India. The company works in medical and surgical equipment, within the healthcare industry. It was incorporated on 26 August 2020 (6+ years old) and is registered under CIN U33113TG2020PTC143217.

Calynn Formulations has 2 current directors:

The latest financial statements of Calynn Formulations on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.

The CIN (Corporate Identification Number) of Calynn Formulations is U33113TG2020PTC143217. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Calynn Formulations was incorporated on 26 August 2020, making it 6+ years old. It is registered with the Registrar of Companies, Hyderabad.

The peers of Calynn Formulations by revenue are Oreck Pharma Private Limited, Sri Vishnu Organics Private Limited, Glorious Bio Care Private Limited, Kaytross Healthcare Limited, Sirus Pharma Marketing Pvt Ltd and 5 more, all in the Pharma industry (Formulations).

Mariappan Anuradha ceased to be Additional Director on 29 Sep 2023. Janardhana Reddy Pravatareddy ceased to be Director on 08 Aug 2023. Mariappan Anuradha was appointed as Director on 07 Aug 2023. Calynn Formulations has 4 board changes on record in total.

Yes, Calynn Formulations is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-02-0004826).

The registered office of Calynn Formulations is at H No 5 35Ns – B503 Saibaba Colony Kukatpally, Hyderabad, Telangana, India – 500072.

Calynn Formulations operates in the healthcare industry, in the medical and surgical equipment segment.

Calynn Formulations can be reached at its registered office: H No 5 35Ns – B503 Saibaba Colony Kukatpally, Hyderabad, Telangana, India – 500072.